Maze Therapeutics CSBO Sells: Reading Insider Moves
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Uncover ways to make passive income at home. This article provides strategies to help you earn without constant effort.
16,710 articlesWhen a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Anduril CEO Brian Schimpf has quietly steered the defense-tech startup from desert days to a major defense contractor...
SpaceX IPO plans could redefine the space economy, but Blue Origin is positioned to challenge. Learn how to evaluate ...
Alphabet appears to be closing the gap with Nvidia in market value as AI-enabled services, search and cloud growth bo...
A new report shows the U.S. auto industry is no longer the global benchmark, saddled with a $3.3 trillion trade defic...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...
The Dow crosses the 50,000 threshold for the first time, rising over 1,200 points in a single session. Analysts call ...
Inflation and eroding wages are reshaping Argentina’s shopping carts, with meat markets throttled by a broad-based ar...
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Green Court Capital Management just trimmed its New Oriental Education stake, a move that raises questions about EDU'...
As Nvidia's earnings hours away approach, investors crave clarity on AI demand, profitability, and guidance. This pie...
Is SpaceX heading to the stock market? This article breaks down the IPO question with insights inspired by Jim Cramer...